Human SRMAtlas: A Resource of Targeted Assays to Quantify the Complete Human Proteome.
Kusebauch, Ulrike; Campbell, David S; Deutsch, Eric W; Chu, Caroline S; Spicer, Douglas A; Brusniak, Mi-Youn; Slagel, Joseph; Sun, Zhi; Stevens, Jeffrey; Grimes, Barbara; Shteynberg, David; Hoopmann, Michael R; Blattmann, Peter; Ratushny, Alexander V; Rinner, Oliver; Picotti, Paola; Carapito, Christine; Huang, Chung-Ying; Kapousouz, Meghan; Lam, Henry; Tran, Tommy; Demir, Emek; Aitchison, John D; Sander, Chris; Hood, Leroy; Aebersold, Ruedi; Moritz, Robert L.
; 166(3): 766-778, 2016 Jul 28.
Artigo em Inglês | MEDLINE | ID: mdl-27453469
The Role of Docetaxel in Non-Castrate Resistant Metastatic Prostate Cancer: An Evidence-based Case Report.
Feasibility of tri-weekly docetaxel-based chemotherapy for elderly patients (age 75 and older) with castration-resistant prostate cancer.
Contemporary Management of the Newly Diagnosed Prostate Cancer Patient with Metastatic Disease at Presentation.
[Prostate cancer-the role of docetaxel on castration-resistant prostate cancer: evaluation of efficacy and subsequent treatment].
[Primary Squamous Cell Carcinoma of the Prostate in which Docetaxel Therapy was Effective : A Case Report].
Moznosti chemoterapie v lécbe karcinomu prostaty.
[Chinese experts consensus on the treatment of metastatic prostate cancer 2018 edition].
New treatment options for castrate-resistant prostate cancer: a urology perspective.
The role of docetaxel based therapy for prostate cancer in the era of targeted medicine.
Cabazitaxel in Metastatic Castration-Resistant Prostate Cancer Patients Progressing after Docetaxel: A Prospective Single-Center Study.